In the case of MLL-AF9-induced AML in mice, KMT2D was found to support this MLL-r leukemia, whereas its deletion led to enhanced myelopoiesis and myeloid differentiation and, thus, protected the animals from AML-related death [168]. This evidence concerns the gene MLLT3 and leukemia.